Leerink Partners Maintains Outperform Rating on CVS Health, $112 Target
Leerink Partners maintained its Outperform rating and $112 price target for CVS Health. The target implies 30.0% upside from the Oct. 9 close of $86.16.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.